Last reviewed · How we verify

AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP

SEARCH Research Foundation · Phase 3 active Small molecule

AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP is a Antiretroviral combination therapy (NRTI + NNRTI or NRTI + NNRTI) Small molecule drug developed by SEARCH Research Foundation. It is currently in Phase 3 development for HIV-1 infection treatment and prevention.

These are combination antiretroviral regimens that inhibit HIV reverse transcriptase and protease to suppress viral replication.

These are combination antiretroviral regimens that inhibit HIV reverse transcriptase and protease to suppress viral replication. Used for HIV-1 infection treatment and prevention.

At a glance

Generic nameAZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP
SponsorSEARCH Research Foundation
Drug classAntiretroviral combination therapy (NRTI + NNRTI or NRTI + NNRTI)
TargetHIV reverse transcriptase, HIV integrase
ModalitySmall molecule
Therapeutic areaInfectious Disease / Virology
PhasePhase 3

Mechanism of action

The combinations pair nucleoside reverse transcriptase inhibitors (AZT, 3TC, D4T) or integrase inhibitors (Truvada contains tenofovir/emtricitabine) with the non-nucleoside reverse transcriptase inhibitor (NVP/nevirapine) to block multiple steps of HIV replication. By targeting reverse transcriptase through different mechanisms, these regimens reduce the likelihood of resistance development and achieve sustained viral suppression.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP

What is AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP?

AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP is a Antiretroviral combination therapy (NRTI + NNRTI or NRTI + NNRTI) drug developed by SEARCH Research Foundation, indicated for HIV-1 infection treatment and prevention.

How does AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP work?

These are combination antiretroviral regimens that inhibit HIV reverse transcriptase and protease to suppress viral replication.

What is AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP used for?

AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP is indicated for HIV-1 infection treatment and prevention.

Who makes AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP?

AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP is developed by SEARCH Research Foundation (see full SEARCH Research Foundation pipeline at /company/search-research-foundation).

What drug class is AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP in?

AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP belongs to the Antiretroviral combination therapy (NRTI + NNRTI or NRTI + NNRTI) class. See all Antiretroviral combination therapy (NRTI + NNRTI or NRTI + NNRTI) drugs at /class/antiretroviral-combination-therapy-nrti-nnrti-or-nrti-nnrti.

What development phase is AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP in?

AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP is in Phase 3.

What are the side effects of AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP?

Common side effects of AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP include Rash (nevirapine-related), Hepatotoxicity, Nausea, Diarrhea, Lipodystrophy (AZT/D4T-related), Peripheral neuropathy.

What does AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP target?

AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP targets HIV reverse transcriptase, HIV integrase and is a Antiretroviral combination therapy (NRTI + NNRTI or NRTI + NNRTI).

Related